Beam Therapeutics Inc (BEAM)

R&D Expense Growth

-9.02%

Quarterly · Period ending:

BEAM logo

BEAM R&D Expense Growth

Latest reported-9.02%
BEAM Quarterly R&D Growth (QoQ) (0.00% → -9.02%)
High-resolution chart · PNG

BEAM r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Beam Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-9.0199%
5.2873%
-9.5601%
7.8726%
2.9773%
-2.5906%
7.6238%
8.2915%
2.6209%
-39.449%
40.007%
2.5018%
-2.0452%
15.4098%
1.2358%
14.3932%
13.9826%
-32.4144%
77.1799%
19.8477%
-76.0255%
485.8248%
8.8047%
54.1025%
-10.1861%
6.5885%
61.1815%
-1.0804%
38.1414%
-6.8311%
-0.0203%
39.112%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.